Rating History for Cardiome Pharma (CRME) by Mackie Research

More Stocks Rated by Mackie Research | Latest Ratings for CRME
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/15/2017 N/A Upgrade Spec. Buy
(Hold)		 2.80
(2.00)		 1.43
(2.33)		 62.94% Details